View in EDS

1628-P: Changes in HbA1c and Treatment in the Second Year following Initiation of Second-Line Therapy in People with T2D—The Global DISCOVER Study.

Saved in:
Bibliographic Details
Title: 1628-P: Changes in HbA1c and Treatment in the Second Year following Initiation of Second-Line Therapy in People with T2D—The Global DISCOVER Study.
Authors: CHARBONNEL, BERNARD1 (AUTHOR), CHEN, HUNGTA1 (AUTHOR), CID-RUZAFA, JAVIER1 (AUTHOR), FENICI, PETER1 (AUTHOR), GOMES, MARILIA B.1 (AUTHOR), SARAIVA, GABRIELA LUPORINI1 (AUTHOR), MEDINA, JESUS1 (AUTHOR), NICOLUCCI, ANTONIO1 (AUTHOR), POCOCK, STUART1 (AUTHOR), SHESTAKOVA, MARINA V.1 (AUTHOR), SHIMOMURA, IICHIRO1 (AUTHOR), SADIKOT, SHAUKAT M.1 (AUTHOR), SURMONT, FILIP1 (AUTHOR), TANG, FENGMING1 (AUTHOR), VORA, JITEN1 (AUTHOR), WATADA, HIROTAKA1 (AUTHOR), KHUNTI, KAMLESH1 (AUTHOR)
Source: Diabetes. 2019 Supplement, Vol. 68, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:00121797
DOI:10.2337/db19-1628-P